carol
08-08-2004, 05:29 AM
Hi Rose,
I just remembered that on the consent form I signed for the clinical traiI it states:
"Although the cause and risks of bleeding in most subjects are not completely known, it is possible that administration of rhuMab VEGF (Avastin) could cause or increase bleeding at tumor sites, including tumors in the brain. Bleeding at tumor sites, particularly those in the brain, could result in permanent disability or death. If you currently have brain metastases,you may not participate in this study."
It sounds as though your brain mets are on their way out, so maybe once they are resolved Avastin might be a possibility. Feel free to email me. Regards, Carol
I just remembered that on the consent form I signed for the clinical traiI it states:
"Although the cause and risks of bleeding in most subjects are not completely known, it is possible that administration of rhuMab VEGF (Avastin) could cause or increase bleeding at tumor sites, including tumors in the brain. Bleeding at tumor sites, particularly those in the brain, could result in permanent disability or death. If you currently have brain metastases,you may not participate in this study."
It sounds as though your brain mets are on their way out, so maybe once they are resolved Avastin might be a possibility. Feel free to email me. Regards, Carol